Enanta Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-09-30 |
2025-09-30 |
2026-09-30 |
2027-09-30 |
2028-09-30 |
2029-09-30 |
| Przychód (średnia) |
71.21 |
63.02 |
65.58 |
65.20 |
59.75 |
46.10 |
| Przychód Δ r/r |
0.00% |
-11.50% |
4.05% |
-0.57% |
-8.36% |
-22.85% |
| Przychód (min) |
70.70 |
55.46 |
36.11 |
63.23 |
49.84 |
38.45 |
| Przychód (max) |
72.18 |
70.74 |
101.55 |
67.17 |
71.26 |
54.98 |
| EBITDA (średnia) |
-61.39 |
-54.33 |
-56.53 |
-56.21 |
-51.51 |
-39.74 |
| EBIT (średnia) |
-61.81 |
-54.70 |
-56.92 |
-56.59 |
-51.86 |
-40.01 |
| EBIT % |
-86.80% |
-86.80% |
-86.80% |
-86.80% |
-86.80% |
-86.80% |
| Zysk netto (średni) |
-110.14 |
-87.80 |
-87.37 |
-55.01 |
-38.61 |
-49.72 |
| Zysk netto % |
-154.66% |
-139.32% |
-133.23% |
-84.37% |
-64.62% |
-107.85% |
| EPS (średnia) |
-5.28 |
-4.15 |
-3.45 |
-2.60 |
-1.82 |
-2.35 |
| Liczba analityków (Przychody) |
6 |
4 |
4 |
3 |
1 |
1 |
| Liczba analityków (EPS) |
4 |
4 |
4 |
2 |
1 |
1 |
| symbol |
ENTA |
ENTA |
ENTA |
ENTA |
ENTA |
ENTA |